IGMPI facebook Clinical Research
IGMPI Logo
Faculty of Clinical Research and Drug Safety

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular Classroom | Online Mode

Clinical Research

Merck KGaA’s lupus drug fails to meet primary endpoints in SLE cohort of Phase II trial
Merck KGaA’s lupus drug fails to meet primary endpoints in SLE cohort of Phase II trial
Stock takes hit: Biohaven’s pivotal bipolar drug trial fails
Stock takes hit: Biohaven’s pivotal bipolar drug trial fails
Takeda and Protagonist report topline results from rusfertide’s trial
Takeda and Protagonist report topline results from rusfertide’s trial
Reports positive outcomes from trial of Imfinzi : AstraZeneca
Reports positive outcomes from trial of Imfinzi : AstraZeneca
ViiV Healthcare demonstrates positive findings from the phase I study of cabotegravir long-acting injectable investigational formulation
ViiV Healthcare demonstrates positive findings from the phase I study of cabotegravir long-acting injectable investigational formulation
NeuroSense expands data in Phase IIb ALS study with positive update
NeuroSense expands data in Phase IIb ALS study with positive update
MAIA Biotechnology declares positive data from NSCLC therapy trial
Newron’s add-on schizophrenia therapy mets endpoints in Phase II/III trial
Micron Medical's Phase I/II trial, detailed in The Lancet, underscores the safety and efficacy of its measles and rubella microneedle patch (MNP), offering a needle-free vaccination option. Results sh
Micron reveals positive data from needle-free measles and rubella vaccine study
Ionis Pharma reports positive results from the phase 2 study of ION224, demonstrating clinical efficacy in treating NASH/MASH
Merck’s phase 3 KEYNOTE-811 trial of Keytruda in combo with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy meets dual primary endpoint of OS in patients with HER2-positive ad
Grifols documents positive topline outcomes from the phase 3 fibrinogen clinical trial
Grifols documents positive topline outcomes from the phase 3 fibrinogen clinical trial
Bristol Myers Squibb reports CheckMate -9DW trial of Opdivo plus Yervoy meets primary endpoint of OS to treat advanced HCC
Merck declares positive results from trial of pneumonia vaccine